ondansetron has been researched along with Brown Tendon Sheath Syndrome in 2 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Excerpt | Relevance | Reference |
---|---|---|
"We treated a patient who developed transient multifocal encephalopathy with extrapyramidal symptoms (oromandibular dystonia, oculogyric crisis, and limb dystonia) in temporal proximity to ondansetron administration on emergence from general anesthesia." | 3.72 | Ondansetron-induced multifocal encephalopathy. ( Goodman, BP; Ritter, MJ; Sprung, J; Wijdicks, EF, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Macachor, JD | 1 |
Kurniawan, M | 1 |
Loganathan, SB | 1 |
Ritter, MJ | 1 |
Goodman, BP | 1 |
Sprung, J | 1 |
Wijdicks, EF | 1 |
2 other studies available for ondansetron and Brown Tendon Sheath Syndrome
Article | Year |
---|---|
Ondansetron-induced oculogyric crisis.
Topics: Administration, Intravenous; Adult; Anti-Anxiety Agents; Female; Humans; Ocular Motility Disorders; | 2014 |
Ondansetron-induced multifocal encephalopathy.
Topics: Antiemetics; Brain Diseases; Dystonia; Female; Hand; Humans; Mandible; Middle Aged; Mouth; Ocular Mo | 2003 |